Page last updated: 2024-08-17

2,4-dinitrobenzenesulfonic acid and losartan potassium

2,4-dinitrobenzenesulfonic acid has been researched along with losartan potassium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuzzocrea, S; De Sarro, A; Di Paola, R; Genovese, T; Mazzon, E; MuiĆ , C; Patel, NS; Thiemermann, C1
Acet, A; Kaya, E; Parlakpinar, H; Tasdemir, S; Vardi, N1

Other Studies

2 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and losartan potassium

ArticleYear
Erythropoietin reduces the development of experimental inflammatory bowel disease.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:3

    Topics: Animals; Benzenesulfonates; Colitis; Erythropoietin; Immunohistochemistry; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Male; Mice; Neutrophil Infiltration; Peroxidase; Poly Adenosine Diphosphate Ribose; Recombinant Proteins; Tumor Necrosis Factor-alpha; Tyrosine

2004
Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis.
    Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Caspase 3; CD4-Positive T-Lymphocytes; Colitis; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Erythropoietin; Flow Cytometry; Goblet Cells; Male; Melatonin; Rats; Rats, Wistar

2013